Exo Therapeutics logo

Exo Therapeutics

Advancing precision therapeutics for challenging pharmaceutical targets through pioneering technology and world-class research.

11-50 employees · est. 2018

VS
Henlius logo

Henlius

Reliable Quality · Affordable Innovation

492 employees · est. 2010 · Shanghai, China

Henlius is the older company (2018 vs 2010); Henlius is the larger of the two.

Side-by-Side Comparison

Exo Therapeutics Henlius
Founded
2018 2010 older
Headquarters
Not tracked yet Shanghai, China
Employees
11-50 492 larger
Industry
Biotechnology, Health Care, Pharmaceutical Biotechnology, Health Care, Pharmaceutical
Funding Stage
Series B Series Unknown
Total Funding
$103.00M $346.00M
Funding Rounds
2 3
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Precision Therapeutics, Drug Discovery, Small Molecules, ExoSight Platform, Exosites, Enzyme Activity, Oncology, Inflammation, Pharmaceutical Targets, Therapeutic Outcomes, World-class Research, Pioneering Technology, Breakthrough Treatments, Deep Pipeline, Data-driven Research Biopharmaceutical, Oncology Treatments, Monoclonal Antibodies, Biosimilar Drugs, Bio-betters, Novel MAbs, ADC (Antibody-Drug Conjugates), Immunology, Autoimmune Diseases, Clinical-stage Services, Pharmaceutical Manufacturing, Biotech Innovation, Affordable Treatments, Shanghai Fosun Pharmaceutical
Website
exo-therapeutics.com henlius.com
Exo Therapeutics logo

About Exo Therapeutics

Exo Therapeutics, founded in 2018, is a promising biotechnology and pharmaceutical startup that is making waves in the industry with its innovative approach to drug discovery and development. The company's slogan, "Advancing precision therapeutics for challenging pharmaceutical targets through pione...

Henlius logo

About Henlius

Henlius, founded in 2010, has rapidly emerged as a key player in the biopharmaceutical sector, focusing on oncology. The company's slogan, "Reliable Quality · Affordable Innovation," encapsulates its commitment to delivering high-quality and cost-effective treatments to patients globally. Headquart...

We will tell you when either one moves

BounceWatch watches Exo Therapeutics and Henlius for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Exo Therapeutics and Henlius — by email.

Frequently Asked Questions

Exo Therapeutics — Advancing precision therapeutics for challenging pharmaceutical targets through pioneering technology and world-class research.. Henlius — Reliable Quality · Affordable Innovation. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Exo Therapeutics has raised $103.00M while Henlius has raised $346.00M.
Exo Therapeutics and Henlius operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Exo Therapeutics with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Exo Therapeutics on 26 Jul 2024, and Henlius on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy